Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268]

✍ Scribed by Allard, Sabine D.; De Keersmaecker, Brenda; de Goede, Anna L.; Verschuren, Esther J.; Koetsveld, Jeanette; Reedijk, Mariska L.; Wylock, Carolien; De Bel, Annelies V.; Vandeloo, Judith; Pistoor, Frank; Heirman, Carlo; Beyer, Walter E.P.; Eilers, Paul H.C.; Corthals, Jurgen; Padmos, Iman; Thielemans, Kris; Osterhaus, Albert D.M.E.; Lacor, Patrick; van der Ende, Marchina E.; Aerts, Joeri L.; van Baalen, Carel A.; Gruters, Rob A.

• Book ID: 122485899
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 166 KB
• Volume: 150
• Category: Article
• ISSN: 1090-2341
• DOI: 10.1016/j.clim.2013.11.001